IP Verse

Merck Sharp & Dohme Llc Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Merck Sharp & Dohme Llc

Patent:

Title:

Method Of Treating Cancer Using Immune Checkpoint Inhibitor

Applicant:

BRISTOL-MYERS SQUIBB COMPANY

Opposition Date:

2021-10-12

Patent:

Title:

Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases

Applicant:

Opposition Date:

2021-05-26

Patent:

Title:

Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors

Applicant:

Opposition Date:

2018-09-20

Patent Number	Title	Applicant	Opposition Date
EP3322731	Method Of Treating Cancer Using Immune Checkpoint Inhibitor	BRISTOL-MYERS SQUIBB COMPANY	2021-10-12
EP2382228	Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases	AMGEN INC.	2021-05-26
EP2188371	Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors	WYETH LLC	2018-09-20

Top clients of Merck Sharp & Dohme Llc filing patent oppositions

Company:

MERCK SHARP & DOHME LLC

Count:

3

Company	Count
MERCK SHARP & DOHME LLC	3